These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 29880615)

  • 21. Digital spatial profiling of CD4
    Takeuchi M; Miyoshi H; Semba Y; Yamada K; Nakashima K; Sato K; Furuta T; Moritsubo M; Ogura Y; Tanaka K; Imamoto T; Arakawa F; Kohno K; Ohshima K
    Virchows Arch; 2023 Aug; 483(2):255-260. PubMed ID: 37270432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges and perspectives in the immunotherapy of Hodgkin lymphoma.
    Michot JM; Lazarovici J; Ghez D; Danu A; Fermé C; Bigorgne A; Ribrag V; Marabelle A; Aspeslagh S
    Eur J Cancer; 2017 Nov; 85():67-77. PubMed ID: 28892775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microenvironment in classical Hodgkin lymphoma].
    Mottok A
    Pathologe; 2020 May; 41(3):254-260. PubMed ID: 32239325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The critical role of CD4+ T cells in PD-1 blockade against MHC-II-expressing tumors such as classic Hodgkin lymphoma.
    Nagasaki J; Togashi Y; Sugawara T; Itami M; Yamauchi N; Yuda J; Sugano M; Ohara Y; Minami Y; Nakamae H; Hino M; Takeuchi M; Nishikawa H
    Blood Adv; 2020 Sep; 4(17):4069-4082. PubMed ID: 32870971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells.
    Greaves P; Clear A; Owen A; Iqbal S; Lee A; Matthews J; Wilson A; Calaminici M; Gribben JG
    Blood; 2013 Oct; 122(16):2856-63. PubMed ID: 24004665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.
    Tiacci E; Döring C; Brune V; van Noesel CJ; Klapper W; Mechtersheimer G; Falini B; Küppers R; Hansmann ML
    Blood; 2012 Nov; 120(23):4609-20. PubMed ID: 22955914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classical Hodgkin Lymphoma With Aberrant CD8 Expression: A Clinicopathologic Study of Five Cases.
    Mirzamani N; Zhang X; Brody J; Spitzer SG; Sen F; Hsu P
    Int J Surg Pathol; 2019 Apr; 27(2):166-173. PubMed ID: 30058423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
    Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
    Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment.
    Masel R; Roche ME; Martinez-Outschoorn U
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 9p24.1 alterations and programmed cell death 1 ligand 1 expression in early stage unfavourable classical Hodgkin lymphoma: an analysis from the German Hodgkin Study Group NIVAHL trial.
    Gerhard-Hartmann E; Goergen H; Bröckelmann PJ; Mottok A; Steinmüller T; Grund J; Zamò A; Ben-Neriah S; Sasse S; Borchmann S; Fuchs M; Borchmann P; Reinke S; Engert A; Veldman J; Diepstra A; Klapper W; Rosenwald A
    Br J Haematol; 2022 Jan; 196(1):116-126. PubMed ID: 34520052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.
    Juszczynski P; Ouyang J; Monti S; Rodig SJ; Takeyama K; Abramson J; Chen W; Kutok JL; Rabinovich GA; Shipp MA
    Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13134-9. PubMed ID: 17670934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometry CD4(+)CD26(-)CD38(+) lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes.
    Di Gaetano R; Gasparetto V; Padoan A; Callegari B; Candiotto L; Sanzari MC; Scapinello A; Tagariello G
    Ann Hematol; 2014 Aug; 93(8):1319-26. PubMed ID: 24627194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells.
    Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M
    Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PD-1 and PD-L1 Immunohistochemistry as a Diagnostic Tool for Classic Hodgkin Lymphoma in Small-volume Biopsies.
    Volaric A; Bacchi CE; Gru AA
    Am J Surg Pathol; 2020 Oct; 44(10):1353-1366. PubMed ID: 32649320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel scoring system for TIGIT expression in classic Hodgkin lymphoma.
    Annibali O; Bianchi A; Grifoni A; Tomarchio V; Tafuri M; Verri M; Avvisati G; Crescenzi A
    Sci Rep; 2021 Mar; 11(1):7059. PubMed ID: 33782477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.
    Szydłowski M; Prochorec-Sobieszek M; Szumera-Ciećkiewicz A; Derezińska E; Hoser G; Wasilewska D; Szymańska-Giemza O; Jabłońska E; Białopiotrowicz E; Sewastianik T; Polak A; Czardybon W; Gałęzowski M; Windak R; Zaucha JM; Warzocha K; Brzózka K; Juszczyński P
    Blood; 2017 Sep; 130(12):1418-1429. PubMed ID: 28698206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma.
    Cader FZ; Hu X; Goh WL; Wienand K; Ouyang J; Mandato E; Redd R; Lawton LN; Chen PH; Weirather JL; Schackmann RCJ; Li B; Ma W; Armand P; Rodig SJ; Neuberg D; Liu XS; Shipp MA
    Nat Med; 2020 Sep; 26(9):1468-1479. PubMed ID: 32778827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
    Loo EY; Medeiros LJ; Aladily TN; Hoehn D; Kanagal-Shamanna R; Young KH; Lin P; Bueso-Ramos CE; Manning JT; Patel K; Thomazy V; Brynes RK; Goswami M; Fayad LE; Miranda RN
    Am J Surg Pathol; 2013 Aug; 37(8):1290-7. PubMed ID: 23774171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
    Chetaille B; Bertucci F; Finetti P; Esterni B; Stamatoullas A; Picquenot JM; Copin MC; Morschhauser F; Casasnovas O; Petrella T; Molina T; Vekhoff A; Feugier P; Bouabdallah R; Birnbaum D; Olive D; Xerri L
    Blood; 2009 Mar; 113(12):2765-3775. PubMed ID: 19096012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.